ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

FLDM Fluidigm Corporation

3.71
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Fluidigm Corporation NASDAQ:FLDM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.71 3.69 4.03 0 01:00:00

Specialized Disclosure Report (sd)

31/05/2022 12:31pm

Edgar (US Regulatory)



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
FORM SD
SPECIALIZED DISCLOSURE REPORT
 __________________________
Standard BioTools Inc.
(Exact name of the registrant as specified in its charter)
 __________________________
Delaware
001-34180
77-0513190
(State or other jurisdiction of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
    2 Tower Place, Suite 2000, South San Francisco, California                   94080
         (Address of principal executive offices)                         (Zip Code)

Nicholas Khadder
Senior Vice President, General Counsel, and Secretary
(650) 266-6000
(Name and telephone number, including area code, of the person to contact in connection with this report.)
_________________________
Check the appropriate box to indicate the rule pursuant to which this form is being filed:
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2021.
Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended December 31, 2021.





Section 1 - Conflict Minerals Disclosure
Item 1.01    Conflict Minerals Disclosure and Report
For the reporting period from January 1, 2021 to December 31, 2021, Standard BioTools Inc. (the “Company”) evaluated its current products and determined that certain “conflict minerals,” as defined in Section 1, Item 1.01(d)(3) of Form SD, are necessary to the functionality or production of products manufactured by the Company, which are referred to in this Form SD as “necessary conflict minerals.” Accordingly, the Company conducted a reasonable country of origin inquiry to determine whether during 2021 its necessary conflict minerals originated in the Democratic Republic of the Congo or certain adjoining countries, which are referred to in this Form SD collectively as the “covered countries.” The Company then conducted due diligence designed to conform to the Organisation for Economic Co-operation and Development, or OECD, Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas in order to determine whether any of the Company’s necessary conflict minerals originated from any of the covered countries during 2021 and whether these conflict minerals benefited, directly or indirectly, armed groups in any of the covered countries.
Conflict Minerals Disclosure
In accordance with Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, and this Specialized Disclosure Report on Form SD, the Company is filing a Conflict Minerals Report, which is attached as Exhibit 1.01 hereto. A copy of this Form SD and the Conflict Minerals Report are publicly available at https://investors.fluidigm.com/financial-information/sec-filings.
Information contained on, or that can be accessed through, the Company’s website, does not constitute part of, and is not incorporated by reference into, this Form SD and inclusion of the Company’s website address in this Form SD is an inactive textual reference only.
Item 1.02    Exhibit
In accordance with Rule 13p-1, and this Form SD, the Company is filing its Conflict Minerals Report, which is attached as Exhibit 1.01 to this Form SD.
Section 2    Resource Extraction Issuer Disclosure
Item 2.01    Resource Extraction Issuer Disclosure and Report
Not applicable.
Section 3    Exhibits
Item 3.01    Exhibits
The following exhibit is filed as part of this Form SD.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
STANDARD BIOTOOLS INC.
(Registrant)
By:
/s/ Nicholas Khadder
May 27, 2022
Nicholas Khadder
(Date)
Senior Vice President, General Counsel, and Secretary


1 Year Fluidigm Chart

1 Year Fluidigm Chart

1 Month Fluidigm Chart

1 Month Fluidigm Chart

Your Recent History

Delayed Upgrade Clock